Developer docs
API playgroundTry for free, no card

Search company profiles

Trophic Communications

Full company profile

uuid02ic9oa

Namestring
Trophic Communications
Legal namestring
Trophic Communications GmbH
Websiteurl
trophic.eu
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Trophic Communications GmbH is a Munich-headquartered, privately held strategic communications and investor relations agency founded in December 2017 by Gretchen Schweitzer. The firm exclusively serves biotech and life science companies, ranging from early-stage start-ups through publicly listed biopharmaceutical leaders, with documented experience supporting European and US NASDAQ IPOs. Services are delivered through a multidisciplinary team of approximately 20+ staff combining scientific credentials (PhDs in neuroscience, biochemistry, molecular biology, and pharmaceutical sciences) with specialized communications experience drawn from prior roles at MD Anderson Cancer Center, Max Planck Institute, Feinstein Kean Healthcare, Argot Partners, and Amazon.

The company operates three core service lines: Public Relations (media relations, crisis communications, social media strategy, event support), Investor Relations (financial communications, IPO preparation, peer analysis, roadshow planning, conference support, presentation training), and Strategic Materials (scientific posters, websites, brand identity, mechanism-of-action visuals, corporate Q&A, and presentation development). Case-study validated offerings in Positioning, Visibility, and US Market Recognition address specific client needs around corporate identity and transatlantic capital markets visibility. The business model is B2B professional services with engagements negotiated directly with C-level executives and management teams; no pricing is publicly disclosed.

Customers are based across 20+ countries in Europe and North America. The firm is founder-owned, reports no institutional investors, funding rounds, or parent company, and shows no acquisition activity. Recent directional signals include a 2026 hiring wave adding four Account Executives, a Head of HR, and an Office Manager, and the 2024 hire of Anja Heuer specifically to deepen Nasdaq IPO communications capability. The company does not develop technology products and explicitly excludes AI from its hiring and core service delivery.

Short descriptiontext

Trophic Communications is a Munich-based strategic communications and investor relations agency founded in 2017, serving biotech and life science companies from early-stage start-ups to publicly listed biopharmaceuticals with PR, IR, and strategic materials services across Europe and North America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMunich, Germany
HQ citystring
Munich
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotech public relations, investor relations services, life science communications, strategic communications agency, biotech IPO advisory
Industry3 codes
PRIMARYTHAHAGAG
Event Content Marketing, PR & Media Outreach
Travel & Hospitality/MICE (Meetings, Incentives, Conferences & Exhibitions)/Event Marketing, Sponsorship & Lead Retrieval Services
SECONDARYMPAAAOAH
Litigation PR & Legal Communications
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Reputation Management & Crisis Communications
SECONDARYTHACANAD
Incident Management, Alerts & Crisis Communications
NAICS code1 code
  • Public Relations Agencies54182
SIC code1 code
  • Services-Advertising Agencies7311
Product category
Biotech Communications and Investor Relations Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Professional Services - Communications Consulting
TypeProfessional Services
Description

Revenue generated through providing strategic communications, public relations, and investor relations services to biotech and life science companies. Services include media outreach, thought leadership content, IPO preparation, roadshow support, and crisis communications.

trophic.eu
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Trophic Communications is a strategic communications and investor relations agency that delivers public relations, investor relations, and strategic materials services to biotech and life science companies. Its offerings include media engagement, thought-leadership content, IPO readiness and roadshow support, crisis communications, and the creation of tailored materials such as websites, scientific posters, and social media assets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Achieved high levels of media attention from prominent US and global biotech and financial publications for a German biotech client ahead of Nasdaq IPO
+2 more records
Product overview1 text field

Trophic Communications offers a unified communications and investor relations service portfolio for life science companies, comprising three core service areas: Public Relations (press releases, media relations, crisis communications, conferences, social media, events), Investor Relations (financial communications, IPO preparation, peer analysis, roadshows, conference support, presentation training), and Strategic Materials (scientific posters, websites, branding, mechanisms of action visuals, Q&As, presentations). The company also provides specialized case-study validated offerings in Positioning, Visibility, and US Market Recognition to support biotech companies at various stages from seed funding through IPO.

Product and service6 records
1Public Relations Services
CategoryPublic Relations
Description

Communications services including press releases, media relations and outreach, crisis communications, conference and meetings support, social media strategy, and event planning, designed to build visibility and credibility for life science companies through strategic media engagement, expert-driven content, and thought leadership.

2Investor Relations Services
CategoryInvestor Relations
Description

Financial communications, IPO preparation support, peer analysis, roadshow planning and support, financial conference support, and corporate presentation training for biotech and life science companies. The program is designed to build long-term trust and market visibility through tailored engagement with investors and analysts.

3Strategic Materials Services
CategoryStrategic Communications Materials
Description

Creation of scientific posters, website development and updates, logo and brand development, mechanisms of action visuals, corporate Q&A preparation, and corporate presentation development and updates, designed to maximize reach and impact across channels.

4US Recognition Services
CategoryCross-Border Market Recognition
Description

Specialized services helping European biotech companies establish visibility in the US market ahead of Nasdaq IPOs, including media outreach, positioning, social media strategy, website and corporate video development, and IPO readiness preparation.

5Visibility Services
CategoryVisibility and Media Engagement
Description

Media coverage and messaging services including PR programs, media outreach, and media training to increase visibility among investors, financial community, and potential partners for biotech and life science companies.

6Positioning Services
CategoryCorporate Positioning
Description

Corporate identity development including core messaging definition, differentiation strategy, competitor landscape analysis, brand identity creation, and website development for biotech company launches and strategic communications.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large healthcare and life sciences marketing, PR, and communications firm serving biotech, pharma, and health-tech clients globally. Comparable to Trophic's scientific communications focus but operates at much greater scale and across a broader healthcare communications portfolio.

TypeDirect peer
Description

Specialist life sciences and healthcare public relations and investor relations firm with offices in New York and California. Comparable to Trophic in delivering senior-led, science-literate PR and IR support to biotech clients at clinical and capital-markets milestones.

TypeDirect peer
Description

Specialist PR firm serving life sciences clients, founded by the same individual who founded Trophic. Direct comparability on vertical, service mix, and senior team lineage, though it operates as the predecessor US-affiliated agency.

TypeDirect peer
Description

Boston-based integrated PR, investor relations and digital communications agency focused on biotech, pharma, and healthtech. Directly comparable to Trophic in serving life sciences clients across the full PR-to-IR spectrum, especially around IPO readiness and US capital markets.

5Canale Communications
TypeDirect peer
Description

San Diego-based life sciences communications agency providing public relations, investor relations, and corporate communications to biotech and pharma clients. Closely mirrors Trophic's integrated PR/IR offering and biotech-only vertical focus.

TypeDirect peer
Description

Investor relations and public relations agency specialized in life sciences, with deep expertise in biotech IR, earnings, and IPO communications. Senior Advisor Joe Rayne's prior affiliation highlights direct comparability to Trophic's IR offering.

TypeDirect peer
Description

New York-based public relations and investor relations firm dedicated to the life sciences industry. Overlaps directly with Trophic on PR, IR, and strategic communications for biotech and pharma clients across early-stage and public company stages.

TypeEmerging player
Description

Full-service public relations and marketing agency with a life sciences practice covering biotech, pharma, and patient advocacy. Comparable to Trophic for scientific storytelling and patient/community communications but with a broader marketing scope.

TypeBroad incumbent
Description

Large strategic communications and advisory firm with a substantial healthcare and biotech IR/PR practice. Comparable to Trophic on biotech IR and IPO communications but at meaningfully larger scale and broader service breadth.

TypeDirect peer
Description

Long-standing life sciences communications consultancy where Trophic's founder cut her teeth leading the entire Corporate Practice. Directly comparable on biotech and pharma PR/IR depth and consultancy model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles19 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Trophic Communications

Biotech Communications and Investor Relations Servicestrophic.eu

Trophic Communications is a Munich-based strategic communications and investor relations agency founded in 2017, serving biotech and life science companies from early-stage start-ups to publicly listed biopharmaceuticals with PR, IR, and strategic materials services across Europe and North America.

What Trophic Communications does

Trophic Communications GmbH is a Munich-headquartered, privately held strategic communications and investor relations agency founded in December 2017 by Gretchen Schweitzer. The firm exclusively serves biotech and life science companies, ranging from early-stage start-ups through publicly listed biopharmaceutical leaders, with documented experience supporting European and US NASDAQ IPOs. Services are delivered through a multidisciplinary team of approximately 20+ staff combining scientific credentials (PhDs in neuroscience, biochemistry, molecular biology, and pharmaceutical sciences) with specialized communications experience drawn from prior roles at MD Anderson Cancer Center, Max Planck Institute, Feinstein Kean Healthcare, Argot Partners, and Amazon.

The company operates three core service lines: Public Relations (media relations, crisis communications, social media strategy, event support), Investor Relations (financial communications, IPO preparation, peer analysis, roadshow planning, conference support, presentation training), and Strategic Materials (scientific posters, websites, brand identity, mechanism-of-action visuals, corporate Q&A, and presentation development). Case-study validated offerings in Positioning, Visibility, and US Market Recognition address specific client needs around corporate identity and transatlantic capital markets visibility. The business model is B2B professional services with engagements negotiated directly with C-level executives and management teams; no pricing is publicly disclosed.

Customers are based across 20+ countries in Europe and North America. The firm is founder-owned, reports no institutional investors, funding rounds, or parent company, and shows no acquisition activity. Recent directional signals include a 2026 hiring wave adding four Account Executives, a Head of HR, and an Office Manager, and the 2024 hire of Anja Heuer specifically to deepen Nasdaq IPO communications capability. The company does not develop technology products and explicitly excludes AI from its hiring and core service delivery.

Trophic Communications firmographics

Firmographics
Name
Trophic Communications
Legal name
Trophic Communications GmbH
Website
https://trophic.eu
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Trophic Communications is a Munich-based strategic communications and investor relations agency founded in 2017, serving biotech and life science companies from early-stage start-ups to publicly listed biopharmaceuticals with PR, IR, and strategic materials services across Europe and North America.
Ownership category
akta.pro rank

Trophic Communications industry classification

Industry
Product category
Biotech Communications and Investor Relations Services
NAICS
Public Relations Agencies (54182)
SIC
Services-Advertising Agencies (7311)
akta.pro industry
PRIMARYTHAHAGAG
Event Content Marketing, PR & Media Outreach
Travel & Hospitality/MICE (Meetings, Incentives, Conferences & Exhibitions)/Event Marketing, Sponsorship & Lead Retrieval Services
SECONDARYMPAAAOAH
Litigation PR & Legal Communications
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Reputation Management & Crisis Communications
SECONDARYTHACANAD
Incident Management, Alerts & Crisis Communications

Keywords

  • Biotech public relations
  • Investor relations services
  • Life science communications
  • Strategic communications agency
  • Biotech IPO advisory

Where Trophic Communications is headquartered

Location

Headquarters

HQ city
Munich
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Trophic Communications business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Professional Services - Communications Consulting: Revenue generated through providing strategic communications, public relations, and investor relations services to biotech and life science companies. Services include media outreach, thought leadership content, IPO preparation, roadshow support, and crisis communications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Trophic Communications product offering

Product offering

Core offering

Trophic Communications is a strategic communications and investor relations agency that delivers public relations, investor relations, and strategic materials services to biotech and life science companies. Its offerings include media engagement, thought-leadership content, IPO readiness and roadshow support, crisis communications, and the creation of tailored materials such as websites, scientific posters, and social media assets.

Product overview

Trophic Communications offers a unified communications and investor relations service portfolio for life science companies, comprising three core service areas: Public Relations (press releases, media relations, crisis communications, conferences, social media, events), Investor Relations (financial communications, IPO preparation, peer analysis, roadshows, conference support, presentation training), and Strategic Materials (scientific posters, websites, branding, mechanisms of action visuals, Q&As, presentations). The company also provides specialized case-study validated offerings in Positioning, Visibility, and US Market Recognition to support biotech companies at various stages from seed funding through IPO.

Differentiator

Problem solved

Functional benefit

Products and services

  • Public Relations Services Communications services including press releases, media relations and outreach, crisis communications, conference and meetings support, social media strategy, and event planning, designed to build visibility and credibility for life science companies through strategic media engagement, expert-driven content, and thought leadership.
  • Investor Relations Services Financial communications, IPO preparation support, peer analysis, roadshow planning and support, financial conference support, and corporate presentation training for biotech and life science companies. The program is designed to build long-term trust and market visibility through tailored engagement with investors and analysts.
  • Strategic Materials Services Creation of scientific posters, website development and updates, logo and brand development, mechanisms of action visuals, corporate Q&A preparation, and corporate presentation development and updates, designed to maximize reach and impact across channels.
  • US Recognition Services Specialized services helping European biotech companies establish visibility in the US market ahead of Nasdaq IPOs, including media outreach, positioning, social media strategy, website and corporate video development, and IPO readiness preparation.
  • Visibility Services Media coverage and messaging services including PR programs, media outreach, and media training to increase visibility among investors, financial community, and potential partners for biotech and life science companies.
  • Positioning Services Corporate identity development including core messaging definition, differentiation strategy, competitor landscape analysis, brand identity creation, and website development for biotech company launches and strategic communications.

Quantifiable outcome

  • Achieved high levels of media attention from prominent US and global biotech and financial publications for a German biotech client ahead of Nasdaq IPO
  • +2 more outcomes

Companies that use Trophic Communications

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Trophic Communications technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Trophic Communications partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Trophic Communications competitors and assessment

Company assessment

Broad incumbents

  • Real Chemistry: Large healthcare and life sciences marketing, PR, and communications firm serving biotech, pharma, and health-tech clients globally. Comparable to Trophic's scientific communications focus but operates at much greater scale and across a broader healthcare communications portfolio.
  • ICR (formerly Westwicke): Large strategic communications and advisory firm with a substantial healthcare and biotech IR/PR practice. Comparable to Trophic on biotech IR and IPO communications but at meaningfully larger scale and broader service breadth.

Direct peers

  • Russo Partners: Specialist life sciences and healthcare public relations and investor relations firm with offices in New York and California. Comparable to Trophic in delivering senior-led, science-literate PR and IR support to biotech clients at clinical and capital-markets milestones.
  • MacDougall Biomedical Communications: Specialist PR firm serving life sciences clients, founded by the same individual who founded Trophic. Direct comparability on vertical, service mix, and senior team lineage, though it operates as the predecessor US-affiliated agency.
  • LaVoieHealthScience: Boston-based integrated PR, investor relations and digital communications agency focused on biotech, pharma, and healthtech. Directly comparable to Trophic in serving life sciences clients across the full PR-to-IR spectrum, especially around IPO readiness and US capital markets.
  • Canale Communications: San Diego-based life sciences communications agency providing public relations, investor relations, and corporate communications to biotech and pharma clients. Closely mirrors Trophic's integrated PR/IR offering and biotech-only vertical focus.
  • Argot Partners: Investor relations and public relations agency specialized in life sciences, with deep expertise in biotech IR, earnings, and IPO communications. Senior Advisor Joe Rayne's prior affiliation highlights direct comparability to Trophic's IR offering.
  • LifeSci Communications: New York-based public relations and investor relations firm dedicated to the life sciences industry. Overlaps directly with Trophic on PR, IR, and strategic communications for biotech and pharma clients across early-stage and public company stages.
  • Feinstein Kean Healthcare: Long-standing life sciences communications consultancy where Trophic's founder cut her teeth leading the entire Corporate Practice. Directly comparable on biotech and pharma PR/IR depth and consultancy model.

Emerging players

  • JPA Health: Full-service public relations and marketing agency with a life sciences practice covering biotech, pharma, and patient advocacy. Comparable to Trophic for scientific storytelling and patient/community communications but with a broader marketing scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

Trophic Communications social profiles

Digital presence

Trophic Communications financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Trophic Communications leadership team

Management profile

Number of profiles

Profiles19 records

Trophic Communications funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Trophic Communications M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trophic Communications

What does Trophic Communications do?

Trophic Communications is a strategic communications and investor relations agency that delivers public relations, investor relations, and strategic materials services to biotech and life science companies. Its offerings include media engagement, thought-leadership content, IPO readiness and roadshow support, crisis communications, and the creation of tailored materials such as websites, scientific posters, and social media assets.

Is Trophic Communications a public or private company?

Trophic Communications is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Trophic Communications founded?

Trophic Communications was founded in 2017. It employs 11 to 50 people.

Where is Trophic Communications based?

Trophic Communications is headquartered in Munich, Germany, in the Europe region.

How does Trophic Communications make money?

One revenue line is on record: professional Services - Communications Consulting.

Who are Trophic Communications's main competitors?

Broad incumbents on record are Real Chemistry and ICR (formerly Westwicke). Direct peers are Russo Partners, MacDougall Biomedical Communications, LaVoieHealthScience, Canale Communications, Argot Partners, LifeSci Communications and Feinstein Kean Healthcare. JPA Health is listed as an emerging player.

Does Trophic Communications have an API?

No public API is recorded for Trophic Communications.

What industry is Trophic Communications in?

Trophic Communications's product category is Biotech Communications and Investor Relations Services. Its primary akta.pro industry code is THAHAGAG, Event Content Marketing, PR & Media Outreach, with a secondary code of MPAAAOAH, Litigation PR & Legal Communications. Its NAICS code is 54182 and its SIC code is 7311.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals